ISPOR GLOBAL GROUPS- USE OF MCDA IN HTA, COVERAGE AND REIMBURSEMENT DECISION-MAKING- EXPERIENCE AND INSIGHTS FROM EMEA, LATIN AMERICA AND ASIA-PACIFIC
Author(s)
Moderator: Zoltan Kalo, PhD, 1) Semmelweis University; 2) Syreon Research Institute, Budapest, PE, Hungary
Speakers: Ataru Igarashi, PhD, Unit of Public Health and Preventive Medicine, Yokohama City University, Yokohama, Japan; Ivett Jakab, MSc, Patient Policy Unit, Syreon Research Institute, Budapest, Hungary; Ramiro E. Gilardino, MD, MSc, ISPOR, Lawrenceville, NJ, USA
Presentation Documents
MCDA improves objective decision-making by evaluating multiple, sometimes conflicting criteria. Its potential applications in health care decisions have been discussed widely, especially to support health technology assessment (HTA) and appraisal processes. A growing interest in the use of MCDA in HTA and supporting health coverage and reimbursement decisions has been observed across ISPOR global regions. In this session, the expert speakers from Latin America, Asia-Pacific and EMEA will share experiences and insights of MCDA application in HTA and coverage decision making by presenting case studies. They will also discuss key issues, challenges, lessons learned, and future potential of MCDA across ISPOR global regions.
Conference/Value in Health Info
2019-11, ISPOR Europe 2019, Copenhagen, Denmark